Chennai

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

"The recommendations of the SEC were evaluated by another experts committee after which DCGI had sought additional data from the firm," a source said.

The DCGI gave its approval Friday, the source said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android